Status:
COMPLETED
Monitoring and Peer Support to Improve Treatment Adherence and Outcomes
Lead Sponsor:
COPD Foundation
Conditions:
Chronic Obstructive Pulmonary Disease
Obstructive Sleep Apnea
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
The O2VERLAP study investigators would like to find out if individuals living with both COPD and OSA would benefit from an online, educational curriculum, coupled with access to peer support (i.e. tel...
Detailed Description
The O2VERLAP study focuses on a subset of the Chronic Obstructive Pulmonary Disease (i.e. COPD) community that are also living with a diagnosis of Sleep Apnea (i.e. SA); having a diagnosis of both COP...
Eligibility Criteria
Inclusion
- Age: \>40 years
- Primary language: English
- Diagnosed with both Chronic Obstructive Pulmonary Disease (COPD) and Obstructive Sleep Apnea (OSA)
- Prescription for positive airway pressure therapy (PAP). There should be no minimum or maximum flow required (i.e., no limitation on PAP modality).
- Access to the internet viand a PC, tablet, or smart phone to complete all study activities from home or remotely
- PAP device with wireless modem
Exclusion
- Non-English speakers
- Life expectancy less than or equal to six months
Key Trial Info
Start Date :
February 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2019
Estimated Enrollment :
294 Patients enrolled
Trial Details
Trial ID
NCT03446768
Start Date
February 1 2018
End Date
October 31 2019
Last Update
December 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
COPD Foundation Inc.
Miami, Florida, United States, 33134